Table 1.
Characteristics at diagnosis
| Autoimmune hepatitis | AIH‐PBC | AIH‐PSC | |
|---|---|---|---|
| Patients, n (%) | 406 (87) | 30 (6) | 40 (9) |
| Female, n (%) | 315 (78) | 27 (90) | 24 (60) |
| Age in years, median (range) | 46 (2‐88) | 46 (16‐70) | 31 (12‐77) |
| MELD‐score, median (range) | 10 (0‐32) | 7 (1‐22) | 8 (1‐17) |
| IgG g/L, median (range) | 26 (7‐91) | 22 (8‐59) | 22 (13‐51) |
| ALT U/L, median (range) | 513 (11‐4693) | 268 (18‐2649) | 273 (46‐2500) |
| Cirrhosis, n (%) | 57 (18) | 4 (14) | 3 (9) |
| ANA and or SMA positive, n (%) | 333 (88) | 20 (72) | 32 (91) |
| ANA positive, n (%) | 268 (74) | 13 (43) | 23 (70) |
| SMA positive, n (%) | 217 (63) | 15 (60) | 20 (59) |
Abbreviations: AIH‐PBC, autoimmune hepatitis with concomitant primary biliary cholangitis; AIH‐PSC, autoimmune hepatitis with concomitant primary sclerosing cholangitis; ALT, alanine aminotransferase; ANA, anti‐nuclear antibody; IgG, immunoglobulin G; MELD, model for end‐stage liver disease; SMA, smooth muscle antibody.